Cannabinoid-based Drug Discovery and Development Designed to Benefit Cancer Patients

Cannabinoid-based Drug Discovery and Development Designed to Benefit Cancer Patients

0 0 about 1 year ago
This week in The Onco’Zine Brief Peter Hofland, Ph.D talks with Guy Chamberland, M.Sc., Ph.D, about medicinal cannabis.

Chamberland, is a Master Herbalist as well as Chief Executive Officer and Chief Scientific Officer of Tetra Bio-Pharma, a biopharmaceutical company developing cannabinoid-based drugs.

Tetra Bio-Pharma has a clinical development program aimed at bringing novel drugs and treatments to patients and their healthcare providers.

To do this, the Company has several ... See More

Find us on Facebook